McHugh, Catherine M. http://orcid.org/0000-0002-4891-4966
Ho, Nicholas
Iorfino, Frank
Crouse, Jacob J.
Nichles, Alissa
Zmicerevska, Natalia
Scott, Elizabeth
Glozier, Nick
Hickie, Ian B.
Article History
Received: 20 February 2022
Accepted: 21 December 2022
First Online: 28 February 2023
Declarations
:
: Catherine M. McHugh, Frank Iorfino, Jacob J Crouse, Alissa Nichles, Natalia Zmicerevska, Nicholas Ho, and Nick Glozier report no conflicts of interest. Elizabeth Scott is the clinical director of the St Vincent’s Youth Mental health programme. She has received honoraria for educational seminars related to the clinical management of depressive disorders supported by Servier and Eli-Lilly pharmaceuticals. She has participated in a national advisory board for the antidepressant compound Pristiq, manufactured by Pfizer. She was the National Coordinator of an antidepressant trial sponsored by Servier. Ian Hickie was an inaugural Commissioner on Australia’s National Mental Health Commission (2012–18). He is the Co-Director, Health and Policy at the Brain and Mind Centre (BMC) University of Sydney. The BMC operates an early-intervention youth services at Camperdown under contract to headspace. Professor Hickie has previously led community-based and pharmaceutical industry-supported (Wyeth, Eli Lily, Servier, Pfizer, AstraZeneca) projects focused on the identification and better management of anxiety and depression. He was a member of the Medical Advisory Panel for Medibank Private until October 2017, a Board Member of Psychosis Australia Trust and a member of Veterans Mental Health Clinical Reference group. He is the Chief Scientific Advisor to, and an equity shareholder in, Innowell. Innowell has been formed by the University of Sydney and PwC to deliver the $30 m Australian Government-funded ‘Project Synergy’. Project Synergy is a three-year programme for the transformation of mental health services through the use of innovative technologies.